Women who carry germline mutations in BRCA1 and BRCA2 have a substantially increased risk of ovarian, tubal, and peritoneal cancer—about 20%–50% with BRCA1 and 10%–20% with BRCA2.30, 31, 32, 33. The gene discussed is BRCA2; the disease is peritoneum cancer.